Startups
Edit
Affinity Biosensors
http://www.lifescaleinstruments.com/Products/ClinicalLast activity: 20.08.2019
Active - Reference to LifeScale
Affinity Biosensors develops and manufactures award-winning analytical instruments for use in research, manufacturing, and life sciences. Instruments are based on the Company’s exclusive Resonant Mass Measurement (RMM) technology. The sensor is a MEMS-fabricated sensor, enabling the measurement of mass in fluid, with femtogram resolution.
The LifeScale instrument is the current state-of-the-art system to exploit Resonant Mass Measurement technology leading to new, unique and rapid techniques for the measurement and observation of microbe growth and response.
RAPID and PRECISE COUNTS and MASS MEASUREMENT OF INDIVIDUAL MICROBES
LOW SAMPLE VOLUME AND CONCENTRATIONS
SIMPLE SAMPLE PREPARATION
QUANTITATIVE RESULTS
SIMPLE TOUCH-SCREEN SOFTWARE
RAPID RESULTS
LifeScale AST
A well-plate format for rapid (3-3.5 hours) antibiotic susceptibility testing of Gram-negative rods. The semi-automated platform offers high throughput, and excellent statistics. The LifeScale system gives the fastest possible assessment of microbial growth. Performance in antibiotic susceptibility testing has been validated on clinically derived organisms direct from positive blood culture using a custom antibiotic panel.
The LifeScale-AST is CE Marked (IVDD 98/79/EC).
The LifeScale instrument is the current state-of-the-art system to exploit Resonant Mass Measurement technology leading to new, unique and rapid techniques for the measurement and observation of microbe growth and response.
RAPID and PRECISE COUNTS and MASS MEASUREMENT OF INDIVIDUAL MICROBES
LOW SAMPLE VOLUME AND CONCENTRATIONS
SIMPLE SAMPLE PREPARATION
QUANTITATIVE RESULTS
SIMPLE TOUCH-SCREEN SOFTWARE
RAPID RESULTS
LifeScale AST
A well-plate format for rapid (3-3.5 hours) antibiotic susceptibility testing of Gram-negative rods. The semi-automated platform offers high throughput, and excellent statistics. The LifeScale system gives the fastest possible assessment of microbial growth. Performance in antibiotic susceptibility testing has been validated on clinically derived organisms direct from positive blood culture using a custom antibiotic panel.
The LifeScale-AST is CE Marked (IVDD 98/79/EC).
Overview
Location
United States, California, Santa Barbara
Employees
51-200
Total raised
$5M
Founded date
2006
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Affinity Biosensors | “Affinity Biosensors’ LifeScale platform delivers rapid, high-throughput phenotypic antimicrobial susceptibility testing in under four hours, empowering clinical labs to make timely antibiotic decisions and combat drug-resistant infections.... |
Reviews 0
FAQ about Affinity Biosensors
When was Affinity Biosensors founded?
Affinity Biosensors was founded in 2006.
How much funding has Affinity Biosensors raised?
Affinity Biosensors has raised $5M in total across 1 funding round.
What has the press written about Affinity Biosensors?
Parsers VC has collected 2 articles mentioning Affinity Biosensors, among them “Affinity Biosensors”.
Is Affinity Biosensors still active?
Yes, Affinity Biosensors is active; its latest activity on Parsers VC dates from Aug 20, 2019.